RETeval: Supernormal Flicker ERGs in Eyes With Central Retinal Vein Occlusion: Clinical Characteristics, Prognosis, and Effects of Anti-VEGF Agent
The purpose of the study was to determine the clinical characteristics, prognosis, and effect of anti-vascular endothelial growth factor (VEGF) agents on eyes with a central retinal vein occlusion (CRVO) with and without supernormal flicker ERG amplitudes. READ FULL PUBLICATION
RETeval: Evaluation of light- and dark-adapted ERGs using a mydriasis-free, portable system: clinical classifications and normative data
The purpose of this study was to determine the intra-visit reliability and diagnostic capability of a handheld, mydriasisfree ERG, RETeval (LKC Technologies, Gaithersburg, MD, USA), in comparison with the standard clinical ff-ERG by measuring responses recommended by the International Society for Clinical Electrophysiology of Vision (ISCEV).
RETeval: Role of a Mydriasis-Free, Full-Field Flicker ERG Device in the Detection of Diabetic Retinopathy
The purpose of this research is to determine if the RETeval system can be used for the screening of diabetic retinopathy (DR) to provide early diagnosis.
Discovery of a Cynomolgus Monkey Family With Retinitis Pigmentosa
Purpose: To accelerate the development of new therapies, an inherited retinal degeneration model in a nonhuman primate would be useful to confirm the efficacy in preclinical studies. In this study, we describe the discovery of retinitis pigmentosa in a cynomolgus monkey (Macaca fascicularis) pedigree. Methods: First, screening with fundus photography was performed on 1443 monkeys at the […]
Warning: This product can expose you to chemicals including lead, which is known to the State of California to cause cancer and birth defects or other reproductive harm. For more information go to